Vaxcyte, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vaxcyte, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vaxcyte, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | M | 2.03 | 2,500 | 5,075 | 202,468 | |
| Feb 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 26.95 | 2,500 | 67,375 | 1,562 | 4.1 K to 1.6 K (-61.55 %) |
| Feb 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Buy | M | 2.03 | 2,500 | 5,075 | 4,062 | 1.6 K to 4.1 K (+160.05 %) |
| Feb 16 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Option Exercise | M | 1.79 | 2,500 | 4,475 | 23,926 | |
| Feb 16 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Sell | S | 27.27 | 316 | 8,617 | 77,899 | 78.2 K to 77.9 K (-0.40 %) |
| Feb 16 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Sell | S | 26.56 | 2,184 | 58,007 | 78,215 | 80.4 K to 78.2 K (-2.72 %) |
| Feb 16 2021 | PCVX | Vaxcyte, Inc. | Sauer Paul | SVP Process Dev, Ma ... | Buy | M | 1.79 | 2,500 | 4,475 | 80,399 | 77.9 K to 80.4 K (+3.21 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 28.66 | 6,632 | 190,073 | 1,405,418 | 1.4 M to 1.4 M (-0.47 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 27.64 | 7,567 | 209,152 | 1,412,050 | 1.4 M to 1.4 M (-0.53 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.78 | 26,688 | 714,705 | 1,419,617 | 1.4 M to 1.4 M (-1.85 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.75 | 37,271 | 959,728 | 1,446,305 | 1.5 M to 1.4 M (-2.51 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 28.75 | 93,740 | 2,695,025 | 1,483,576 | 1.6 M to 1.5 M (-5.94 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 28.07 | 88,756 | 2,491,381 | 1,577,316 | 1.7 M to 1.6 M (-5.33 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 27.12 | 38,248 | 1,037,286 | 1,666,072 | 1.7 M to 1.7 M (-2.24 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 26.06 | 28,922 | 753,707 | 1,704,320 | 1.7 M to 1.7 M (-1.67 %) |
| Feb 10 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.64 | 50,874 | 1,304,409 | 1,733,242 | 1.8 M to 1.7 M (-2.85 %) |
| Feb 04 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.06 | 2,768 | 69,366 | 1,784,116 | 1.8 M to 1.8 M (-0.15 %) |
| Feb 04 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.13 | 14,234 | 357,700 | 1,786,884 | 1.8 M to 1.8 M (-0.79 %) |
| Feb 02 2021 | PCVX | Vaxcyte, Inc. | Hopfner Robert Lorne | Director | Sell | S | 25.07 | 2,000 | 50,140 | 1,801,118 | 1.8 M to 1.8 M (-0.11 %) |